Sora Kim

Title: Sora Kim: Innovator in Pharmacological Research

Introduction

Sora Kim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmacology, particularly in the development of novel therapeutic agents. His work focuses on addressing various medical conditions through innovative chemical compounds.

Latest Patents

Sora Kim holds a patent for "Thienopyrimidinone derivatives as mGluR1 antagonists." This patent discloses thienopyrimidinone derivatives that act as antagonists on metabotropic glutamate receptor subtype 1. These derivatives exhibit pharmacological activity against a range of metabotropic glutamate receptor-related diseases, including neuropathic pain, migraines, anxiety disorders, schizophrenia, urinary incontinence, and neurodegenerative diseases such as Parkinson's and Alzheimer's diseases. The patent also includes methods for preparing these derivatives and pharmaceutical compositions containing them as active ingredients.

Career Highlights

Sora Kim is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in pharmacology. His innovative approach has led to advancements in the treatment of various medical conditions, showcasing his commitment to improving healthcare through scientific research.

Collaborations

Sora Kim collaborates with notable colleagues, including Hyunah Choo and Sun Joon Min. These partnerships enhance the research efforts at the Korea Institute of Science and Technology, fostering a collaborative environment that drives innovation.

Conclusion

Sora Kim's contributions to pharmacological research through his patented inventions highlight his role as a key innovator in the field. His work not only addresses critical health issues but also paves the way for future advancements in medical treatments.